TheraRadar
Data updated: Jun 28, 2026

TECHNESCAN MAG3 (technetium tc-99m mertiatide kit) · CURIUM

Renal Approved 1990-06-15

Technetium Tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (See Pediatric Use. ) It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.

Source: FDA Label
2
Indications
--
Phase 3 Trials
36
Years on Market

Details

Status
Prescription
First Approved
1990-06-15
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

TECHNESCAN MAG3 Approval History

1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
9 FDA actions from 1990 to 2014
Jul 2014 SUPPL
Mfg · Manufacturing (CMC)
Mar 2001 SUPPL
Mfg · Manufacturing (CMC)
Apr 1998 SUPPL
Mfg · Manufacturing (CMC)

What TECHNESCAN MAG3 Treats

5 indications

TECHNESCAN MAG3 is approved for 5 conditions since its original approval in 1990. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Congenital Abnormality
  • Acquired Abnormality
  • Renal Failure
  • Urinary Tract Obstruction
  • Calculi
Source: FDA Label

TECHNESCAN MAG3 Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

CURIUM's other novel FDA approvals

Other CDER-designated drugs from the same sponsor (2016–2025).

🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

TECHNESCAN MAG3 FDA Label Details

Indications & Usage

Technetium Tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (See Pediatric Use. ) It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.

Track TECHNESCAN MAG3 with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.